Navigation Links
UF to get $64 million over 6 years to study disability prevention in older Americans
Date:10/2/2009

of mobility disability was lower among a group of older adults who engaged in a structured exercise program for a year, compared with a group of seniors who took part in a health education program for a year.

"This grant reflects NIH's recognition of the excellence of Dr. Pahor's work in this area over the past 10 years," said David S. Guzick, M.D., Ph.D., UF's senior vice president for health affairs and president of the UF&Shands Health System. "It represents the kind of translational research that UF will increasingly be in a position to conduct."

UF is the coordinating center and a field site for the LIFE study, with other field sites at Northwestern University, Pennington Biomedical Research Center a campus of the Louisiana State University system, Stanford University, Tufts University, the University of Pittsburgh, Wake Forest University Health Sciences and Yale University.

Recruitment will begin in early 2010. Eligible participants will be randomly assigned either to take part in a program of moderate-intensity physical activity or a health education program on successful aging. Individuals will be followed for up to three-and-a-half years.

It will be the largest randomized controlled trial ever conducted on physical activity in older adults, and the size of the study will allow scientists to examine the effect of physical activity on a large number of outcomes in ways that have not been possible before.

Primarily, the study seeks to gauge whether there are long-term effects of physical activity interventions on major mobility disability. Investigators will also examine the effects of physical activity on a number of factors, including cognitive function, serious fall injuries, disability in basic activities of daily living, cardiovascular events and hospitalization and nursing home admission. They will also examine quality-of-life measures such as depression symptoms, sleep quality, stress and satisfaction w
'/>"/>

Contact: Czerne M. Reid
czerne@ufl.edu
352-273-5814
University of Florida
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Structure of 450 million year old protein reveals evolutions steps
2. First orchid fossil puts showy blooms at some 80 million years old
3. SyntheMed Completes $2.8 Million Equity Financing
4. Rutgers Genetics receives $7.8 million for autism research
5. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
6. UD leads $5.3-million research project on rice epigenetics
7. Rutgers high school outreach gets $3 million boost from NSF
8. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
9. UD leads $5.3-million research project on rice epigenetics
10. $22 million gift from Alfred Taubman launches new biomedical research institute
11. Nanobiosym awarded $2 million DTRA contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...
(Date:5/17/2013)... a group of proteins in the brain responsible for ... target that could increase cell survival. , The discovery, ... and published in the EMBO journal with ... new therapies for stroke and other brain diseases. , ... which identified a protein, known as SUMO, responsible for ...
(Date:5/17/2013)... Cargo in Efficient and Sustainable Global Logistics Operations) is ... in the efficiency of intermodal loading systems and the ... comprises 29 European organisations with experience in the logistics ... budget totalling 17,000,000 and a duration of three and ... and develop the semantic components and ontologies shared by ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New logistics services that will cut energy consumption and CO2 emissions 2
... simply turn genes on and off now looks to be ... Institute at the University of Utah, report in the July ... showed for the first time that when certain parts of ... to be only minor players in the protein world ?they ...
... barren period when very few therapies were introduced for neglected ... the loss of the equivalent of 92m years' of healthy ... , In the PLoS Medicine analysis, which is based upon ... of the London School of Economics found that around three-quarters ...
... theoretical price of having one's personal genome sequenced just ... $2.2 million, and the goal is to reduce the ... realistic. , The sharp drop is due to a ... (HMS) researchers Jay Shendure, Gregory Porreca, George Church, and ...
Cached Biology News:A 'dimmer switch' for genes 2A 'dimmer switch' for genes 3A step toward the $1,000 personal genome using readily available lab equipment 2
(Date:5/17/2013)... news release is available in German . ... too well: with the naked eye, you can see which ... in the blur of branches through the telephoto lens for ... for researchers who are looking to study proteins, the active ... ETH Zurich,s Institute for Molecular Systems Biology, and her colleagues ...
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... The paradigm of ‘one drug, one ... can help predict the adverse and therapeutic effects of ... of Computational Biology at the Genomics Laboratory, Covance, will ... high-quality genomics when used as part of the QC ... data sets to identify key clinical targets even in ...
(Date:5/16/2013)... May 16, 2013 The Stirling ... Global Cooling, Inc., Athens, OH, USA, won the Outstanding ... the International Society for Biological and Environmental Repositories (ISBER) ... given to one product annually, recognizes the company’s development ... temperature freezer. The award was presented to Global ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2
... therapies have been proposed for regenerative medicine and tissue ... stem cells to efficiently develop into the desired specific ... bone or neurons now limits the potential clinical ... delivering molecules within aggregates of embryonic stem cells via ...
... Baxter Healthcare Corporation,today announced its V-Link Luer-activated ... needleless intravenous (IV) connector to,contain an antimicrobial ... the,United States and Canada. V-Link with VitalShield ... percent or more of specific common pathogens,(infection-causing ...
... CALGARY, April 9 /PRNewswire-FirstCall/ - Oncolytics Biotech ... from its U.K. combination REOLYSIN(R) and carboplatin/paclitaxel,trial. ... Cancer Research, London,and the principal investigator for ... 5th Annual Conference of the British Society ...
Cached Biology Technology:Method to deliver molecules within embryonic stem cells improves differentiation 2Method to deliver molecules within embryonic stem cells improves differentiation 3Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 2Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 3Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 4Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial 3
... for whole-blood clinical diagnostic work in hospitals ... this analyzer makes precise glucose measurements of ... lactate measurements of whole blood, plasma, or ... allows you to have glucose results expressed ...
... This BioSafe room is configured specifically ... and chemical analysis. Panels are precision-joined ... easy to wipe down and disinfect. ... double-wall panel design creates strong, rigid ...
... Phosphate Sensor is a highly sensitive reagent ... product is a purified form of recombinant ... fluorophore MDCC, which is sensitive to changes ... phosphate by Phosphate Sensor is rapid and ...
... This benchtop ductless exhaust hood ... allowing safe indoor release of exhaust. ... contaminants. Over 28" of vertical clearance ... glassware. Includes polypropylene spill tray; options ...
Biology Products: